← Back to AEON

AEON Biopharma, Inc. Class A Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 14/05/2026Sep 2025Filed 14/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 14/05/2026Sep 2024Filed 14/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 14/05/2025
−$1.2−$12−$4.5−$6.6$9.1−$6.2$164−$118
−$0.02−$0.29−$0.39−$0.60$2.28−$11.24$304.00−$227.87
514112114

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.